We also observed an upregulation of PD-L1 in tumor tissue after treatment with ASL, presumably because of the heightened immune pressure elicited by ASL, which was then blocked by the anti-PD-L1 antibody (Fig. 6e). The gene discussed is CD274; the disease is neoplasm.